The role of arginase i in diabetes-induced retinal vascular dysfunction in mouse and rat models of diabetes

Diabetologia

Volumn 56, Issue 3, 2013, Pages 654-662

  Elms, S C ^a   Toque, H A ^a   Rojas, M ^a   Xu, Z ^a   Caldwell, R W ^a   Caldwell, R B ^a,b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arginase; Endothelium; Fundus imaging; Nitric oxide; Retinopathy; Vascular dysfunction

Indexed keywords

ARGINASE 1; ENZYME INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGINASE 1 GENE; ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; GENE ACTIVITY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETIC CODE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RETINA ARTERY; RETINA BLOOD FLOW; RETINA BLOOD VESSEL; RETINA DISEASE; RETINAL VASCULAR DYSFUNCTION; SIGNAL TRANSDUCTION; VASODILATATION;

ACETYLCHOLINE; ANIMALS; ARGINASE; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; NITROPRUSSIDE; RATS; RATS, SPRAGUE-DAWLEY; RETINA; VASODILATION; VASODILATOR AGENTS;

EID: 84877944898     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2789-5     Document Type: Article

References (43)

1. Curtis TM, Gardiner TA, Stitt AW (2009) Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond) 23:1496-1508
2. Clermont AC, Bursell SE (2007) Retinal blood flow in diabetes. Microcirculation 14:49-61
3. Nagaoka T, Sato E, Takahashi A, Yokota H, Sogawa K, Yoshida A (2010) Impaired retinal circulation in patients with type 2 diabetes mellitus: retinal laser Doppler velocimetry study. Invest Ophthalmol Vis Sci 51:6729-6734
4. De Caterina R, Libby P, Peng HB et al (1995) Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60-68
5. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-376
6. Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L (1979) Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J Cyclic Nucl Res 5:211-224
7. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, Dzau VJ (1991) Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88:1663-1671
8. Cohen RA, Tong X (2010) Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease. J Cardiovasc Pharmacol 55:308-316
9. Guzik TJ, Mussa S, Gastaldi D et al (2002) Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 105:1656-1662
10. Lopez-Lopez JG, Moral-Sanz J, Frazziano G et al (2008) Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction. Am J Physiol Lung Cell Mol Physiol 295:L727-L732
11. Xia Y, Zweier JL (1997) Superoxide and peroxynitrite generation from inducible nitric oxide synthase in macrophages. Proc Natl Acad Sci USA 94:6954-6958
12. Pacher P, Obrosova IG, Mabley JG, Szabo C (2005) Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem 12:267-275
13. Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L (2003) Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J 17:2328-2330
14. Berkowitz DE, White R, Li D et al (2003) Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation 108:2000-2006
15. Johnson FK, Johnson RA, Peyton KJ, Durante W (2005) Arginase inhibition restores arteriolar endothelial function in Dahl rats with salt-induced hypertension. Am J Physiol Regul Integr Comp Physiol 288:R1057-R1062
16. Santhanam L, Christianson DW, Nyhan D, Berkowitz DE (2008) Arginase and vascular aging. J Appl Physiol 105:1632-1642
17. Zhang C, Hein TW, Wang W et al (2004) Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension 44:935-943
18. Romero MJ, Iddings JA, Platt DH et al (2012) Diabetes-induced vascular dysfunction involves arginase I. Am J Physiol Heart Circ Physiol 302:H159-H166
19. Romero MJ, Platt DH, Tawfik HE et al (2008) Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 102:95-102
20. Closs EI, Scheld JS, Sharafi M, Forstermann U (2000) Substrate supply for nitric-oxide synthase in macrophages and endothelial cells: role of cationic amino acid transporters. Mol Pharmacol 57:68-74
21. Topal G, Brunet A, Walch L, Boucher JL, David-Dufilho M (2006) Mitochondrial arginase II modulates nitric-oxide synthesis through nonfreely exchangeable L-arginine pools in human endothelial cells. J Pharmacol Exp Ther 318:1368-1374
22. Wu G, Morris SM Jr (1998) Arginine metabolism: nitric oxide and beyond. Biochem J 336(Pt 1):1-17
23. Zhang W, Baban B, Rojas M et al (2009) Arginase activity mediates retinal inflammation in endotoxin-induced uveitis. Am J Pathol 175:891-902
24. Baggio R, Emig FA, Christianson DW, Ash DE, Chakder S, Rattan S (1999) Biochemical and functional profile of a newly developed potent and isozyme-selective arginase inhibitor. J Pharmacol Exp Ther 290:1409-1416
25. Cox JD, Kim NN, Traish AM, Christianson DW (1999) Arginase-boronic acid complex highlights a physiological role in erectile function. Nat Struct Biol 6:1043-1047
26. Shatanawi A, Romero MJ, Iddings JA et al (2011) Angiotensin II-induced vascular endothelial dysfunction through RhoA/Rho kinase/p38 mitogen-activated protein kinase/arginase pathway. Am J Physiol Cell Physiol 300:C1181-C1192
27. Mohiuddin I, Chai H, Lin PH, Lumsden AB, Yao Q, Chen C (2006) Nitrotyrosine and chlorotyrosine: clinical significance and biological functions in the vascular system. J Surg Res 133:143-149
28. Colleluori DM, Ash DE (2001) Classical and slow-binding inhibitors of human type II arginase. Biochemistry 40:9356-9362
29. Toque HA, Tostes RC, Yao L et al (2011) Arginase II deletion increases corpora cavernosa relaxation in diabetic mice. J Sex Med 8:722-733
30. Chandra S, Romero MJ, Shatanawi A, Alkilany AM, Caldwell RB, Caldwell RW (2012) Oxidative species increase arginase activity in endothelial cells through the RhoA/Rho kinase pathway. Br J Pharmacol 165:506-519
31. Horio N, Clermont AC, Abiko A et al (2004) Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats. Diabetologia 47:113-123
32. Noguchi M, Mori A, Sakamoto K, Nakahara T, Ishii K (2009) Vasodilator effects of flunarizine on retinal blood vessels in anesthetized rats. Biol Pharm Bull 32:2068-2071
33. Mori A, Saigo O, Hanada M, Nakahara T, Ishii K (2009) Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats. J Pharmacol Sci 110:160-168
34. Wright WS, Harris NR (2008) Ozagrel attenuates early streptozotocin- induced constriction of arterioles in the mouse retina. Exp Eye Res 86:528-536
35. Wang Z, Yadav AS, Leskova W, Harris NR (2010) Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan. Exp Eye Res 91:670-675
36. Xu H, Manivannan A, Goatman KA et al (2002) Improved leukocyte tracking in mouse retinal and choroidal circulation. Exp Eye Res 74:403-410
37. Iwama D, Miyahara S, Tamura H, Miyamoto K, Hirose F, Yoshimura N (2008) Lack of inducible nitric oxide synthases attenuates leukocyte-endothelial cell interactions in retinal microcirculation. Br J Ophthalmol 92:694-698
38. Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW (2008) C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest Ophthalmol Vis Sci 49:2053-2060
39. Nakakuki T, Ito M, Iwasaki H et al (2005) Rho/Rho-kinase pathway contributes to C-reactive protein-induced plasminogen activator inhibitor-1 expression in endothelial cells. Arterioscler Thromb Vasc Biol 25:2088-2093
40. Beckmann JS, Ye YZ, Anderson PG et al (1994) Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem Hoppe Seyler 375:81-88
41. Iyer RK, Yoo PK, Kern RM et al (2002) Mouse model for human arginase deficiency. Mol Cell Biol 22:4491-4498
42. Ryoo S, Berkowitz DE, Lim HK (2011) Endothelial arginase II and atherosclerosis. Korean J Anesthesiol 61:3-11
43. Hayashi T, Esaki T, Sumi D, Mukherjee T, Iguchi A, Chaudhuri G (2006) Modulating role of estradiol on arginase II expression in hyperlipidemic rabbits as an atheroprotective mechanism. Proc Natl Acad Sci USA 103:10485-10490